- Marketwired•2 months agoProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2016; Exploring Strategic Alternatives to Enhance Shareholder Value
ProPhase Labs, Inc. today reported its net sales were $2.8 million for the three months ended June 30, 2016 as compared to net sales of $2.2 million for the three months ended June 30, 2015. The Company ...
- Marketwired•2 months ago
ProPhase Labs announced today that financial results for the second quarter, ended June 30, 2016, will be released after the market closes on Tuesday, August 9, 2016. A conference call will be held on ...
- Capital Cube•4 months ago
Click here to see latest analysisProPhase Labs, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of ProPhase Labs, Inc. – Mannatech, Incorporated, Reliv’ International, Inc., Rock Creek Pharmaceuticals, Inc., USANA Health Sciences, Inc., Nature’s Sunshine Products, Inc., Nutraceutical International Corporation, Albany Molecular Research, Inc., […] (Read more...) The post ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 appeared first on CapitalCube.
ProPhase Labs, Inc. (PRPH)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||2.06 x 100|
|Ask||2.10 x 1100|
|Day's Range||1.98 - 2.14|
|52wk Range||1.05 - 2.24|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-11.36|
|Avg Vol (3m)||18,845|
|Dividend & Yield||N/A (N/A)|